Dawn Svoronos

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Aneta Fergson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dawn Svoronos:

Company Role Class Num Shares Value Price $ Report Date Ownership
PTC THERAPEUTICS, INC. Director Common Stock 29,017 $794,497 $27.38 09 Jun 2022 Direct
ACELYRIN, Inc. Director Common Stock 0 $0 $2.45 21 May 2025 Direct
Adverum Biotechnologies, Inc. Director Common Stock 0 $0 $4.26 09 Dec 2025 Direct
Xenon Pharmaceuticals Inc. Director Share Option (Right to Buy) 17,012 05 Jun 2025 Direct
Xenon Pharmaceuticals Inc. Director Restricted Share Units 2,645 05 Jun 2025 Direct
ACELYRIN, Inc. Director Director Stock Option (right to buy) 0 21 May 2025 Direct
Adverum Biotechnologies, Inc. Director Stock Option (Right to Buy) 0 09 Dec 2025 Direct
Global Blood Therapeutics, Inc. Director Common Stock 0 $46.99 05 Oct 2022 Direct
Global Blood Therapeutics, Inc. Director Restricted Stock Units 0 05 Oct 2022 Direct
Global Blood Therapeutics, Inc. Director Stock Option (Right to Buy) 0 05 Oct 2022 Direct

Insider Reports Filed by Dawn Svoronos

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ADVM Adverum Biotechnologies, Inc. 09 Dec 2025 7 $0 4 Director 10 Dec 2025, 13:31
ADVM Adverum Biotechnologies, Inc. 17 Jun 2025 1 $0 4 Director 20 Jun 2025, 16:24
XENE Xenon Pharmaceuticals Inc. 05 Jun 2025 2 $0 4 Director 06 Jun 2025, 17:57
SLRN ACELYRIN, Inc. 21 May 2025 4 $0 4 Director 23 May 2025, 16:06
ADVM Adverum Biotechnologies, Inc. 17 Jun 2024 1 $0 4 Director 20 Jun 2024, 16:47
SLRN ACELYRIN, Inc. 07 Jun 2024 1 $0 4 Director 11 Jun 2024, 19:07
XENE Xenon Pharmaceuticals Inc. 05 Jun 2024 1 $0 4 Director 05 Jun 2024, 17:41
XENE Xenon Pharmaceuticals Inc. 24 Aug 2023 1 -$967,500 4 Director 24 Aug 2023, 16:33
ADVM Adverum Biotechnologies, Inc. 09 Jun 2023 1 $0 4 Director 13 Jun 2023, 17:10
XENE Xenon Pharmaceuticals Inc. 02 Jun 2023 1 $0 4 Director 02 Jun 2023, 17:24
SLRN ACELYRIN, Inc. 09 May 2023 5 +$270,000 4 Director 11 May 2023, 21:11
SLRN ACELYRIN, Inc. 04 May 2023 1 $0 4 Director 04 May 2023, 20:24
SLRN ACELYRIN, Inc. 04 May 2023 0 $0 3 Director 04 May 2023, 19:49
/report/000089924322033157-svoronos-dawn-2022-10-05 Global Blood Therapeutics, Inc. 05 Oct 2022 7 $0 4 Director 06 Oct 2022, 16:20
XENE Xenon Pharmaceuticals Inc. 28 Jun 2022 1 $0 4 Director 29 Jun 2022, 17:44
/report/000089924322023597-svoronos-dawn-2022-06-21 Global Blood Therapeutics, Inc. 21 Jun 2022 1 -$51,983 4 Director 22 Jun 2022, 18:00
/report/000089924322022889-svoronos-dawn-2022-06-14 Global Blood Therapeutics, Inc. 14 Jun 2022 4 $0 4 Director 16 Jun 2022, 18:00
ADVM Adverum Biotechnologies, Inc. 10 Jun 2022 1 $0 4 Director 14 Jun 2022, 16:22
PTCT PTC THERAPEUTICS, INC. 09 Jun 2022 1 -$20,074 4 Director 10 Jun 2022, 16:06
ADVM Adverum Biotechnologies, Inc. 16 May 2022 1 +$25,578 4 Director 18 May 2022, 16:43
PTCT PTC THERAPEUTICS, INC. 07 Jan 2022 3 -$19,648 4 Director 11 Jan 2022, 15:14
/report/000089924321025001-svoronos-dawn-2021-06-17 Global Blood Therapeutics, Inc. 17 Jun 2021 5 -$58,793 4 Director 21 Jun 2021, 16:31
PTCT PTC THERAPEUTICS, INC. 09 Jun 2021 1 -$15,288 4 Director 11 Jun 2021, 16:47
XENE Xenon Pharmaceuticals Inc. 03 Jun 2021 1 $0 4 Director 03 Jun 2021, 21:16
ADVM Adverum Biotechnologies, Inc. 12 May 2021 1 $0 4 Director 14 May 2021, 20:04